Advertisement
MCP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/mcp.M300033-MCP200 on June 23, 2003.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M300033-MCP200v1
2/7/443    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Glossary
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Melle, C.
Right arrow Articles by von Eggeling, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Melle, C.
Right arrow Articles by von Eggeling, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 2:443-452, 2003.
© 2003 by The American Society for Biochemistry and Molecular Biology, Inc.


Research

Biomarker Discovery and Identification in Laser Microdissected Head and Neck Squamous Cell Carcinoma with ProteinChip® Technology, Two-dimensional Gel Electrophoresis, Tandem Mass Spectrometry, and Immunohistochemistry*

Christian Melle{ddagger}, Günther Ernst{ddagger}, Bettina Schimmel{ddagger}, Annett Bleul{ddagger}, Sven Koscielny§, Andreas Wiesner, Ralf Bogumil, Ursula Möller||, Dirk Osterloh**, Karl-Jürgen Halbhuber|| and Ferdinand von Eggeling{ddagger},{ddagger}{ddagger}

From the {ddagger} Core Unit Chip Application (CUCA), Institute of Human Genetics and Anthropology, Friedrich-Schiller-University, 07740 Jena, Germany, § Clinic of ENT Diseases, Friedrich-Schiller-University, 07740 Jena, Germany, Ciphergen Biosystems GmbH, 37085 Göttingen, Germany, || Institute of Anatomy II, Friedrich-Schiller-University, 07740 Jena, Germany, and ** SIRS-Lab GmbH, 07745 Jena, Germany

Head and neck cancer is a frequent malignancy with a complex, and up to now not clear etiology. Therefore, despite of improvements in diagnosis and therapy, the survival rate with head and neck squamous-cell carcinomas is poor. For a better understanding of the molecular mechanisms behind the process of tumorigenesis and tumor progression, we have analyzed changes of protein expression between microdissected normal pharyngeal epithelium and tumor tissue by ProteinChip® technology. For this, cryostat sections from head and neck tumors (n = 57) and adjacent mucosa (n = 44) were laser-microdissected and analyzed on ProteinChip arrays. The derived mass spectrometry profiles exhibited numerous statistical differences. One peak significantly higher expressed in the tumor (p = 0.000029) was isolated by two-dimensional gel electrophoresis and identified as annexin V by in-gel proteolytic digestion, peptide mapping, tandem mass spectrometry analysis, and immuno-deplete assay. The relevance of this single marker protein was further evaluated by immunohistochemistry. Annexin-positive tissue areas were re-analyzed on ProteinChip arrays to confirm the identity of this protein. In this study, we could show that biomarker in head and neck cancer can be found, identified, and assessed by combination of ProteinChip technology, two-dimensional gel electrophoresis, and immunohistochemistry. In our experience, however, such studies only make sense if a relatively pure microdissected tumor tissue is used. Only then minute changes in protein expression between normal pharyngeal epithelium and tumor tissue can be detected, and it will become possible to educe a tumor-associated protein pattern that might be used as a marker for tumorigenesis and progression.


{ddagger}{ddagger} To whom correspondence should be addressed: Institut für Humangenetik und Anthropologie, CUCA, 07740 Jena, Germany. Tel.: 0049(0)3641-935526; Fax: 0049(0)3641-935582; E-mail: fegg{at}mti.uni-jena.de


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Anticancer ResHome page
I. CADRON, T. VAN GORP, F. AMANT, I. VERGOTE, P. MOERMAN, E. WAELKENS, A. DAEMEN, R. VAN DE PLAS, B. DE MOOR, and R. ZEILLINGER
The Use of Laser Microdissection and SELDI-TOF MS in Ovarian Cancer Tissue to Identify Protein Profiles
Anticancer Res, April 1, 2009; 29(4): 1039 - 1045.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
R. Ralhan, L. V. DeSouza, A. Matta, S. Chandra Tripathi, S. Ghanny, S. Datta Gupta, S. Bahadur, and K. W. M. Siu
Discovery and Verification of Head-and-neck Cancer Biomarkers by Differential Protein Expression Analysis Using iTRAQ Labeling, Multidimensional Liquid Chromatography, and Tandem Mass Spectrometry
Mol. Cell. Proteomics, June 1, 2008; 7(6): 1162 - 1173.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Melle, G. Ernst, N. Escher, D. Hartmann, B. Schimmel, A. Bleul, H. Thieme, R. Kaufmann, K. Felix, H. M. Friess, et al.
Protein Profiling of Microdissected Pancreas Carcinoma and Identification of HSP27 as a Potential Serum Marker
Clin. Chem., April 1, 2007; 53(4): 629 - 635.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Bouamrani, J. Ternier, D. Ratel, A.-L. Benabid, J.-P. Issartel, E. Brambilla, and F. Berger
Direct-Tissue SELDI-TOF Mass Spectrometry Analysis: A New Application for Clinical Proteomics
Clin. Chem., November 1, 2006; 52(11): 2103 - 2106.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
U. Muller, G. Ernst, C. Melle, R. Guthke, and F. von Eggeling
Convergence of the proteomic pattern in cancer
Bioinformatics, June 1, 2006; 22(11): 1293 - 1296.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. Kriegova, C. Melle, V. Kolek, B. Hutyrova, F. Mrazek, A. Bleul, R. M. du Bois, F. von Eggeling, and M. Petrek
Protein Profiles of Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis
Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1145 - 1154.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
G. Ernst, C. Melle, B. Schimmel, A. Bleul, and F. von Eggeling
Proteohistography--Direct Analysis of Tissue with High Sensitivity and High Spatial Resolution Using ProteinChip Technology
J. Histochem. Cytochem., January 1, 2006; 54(1): 13 - 17.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
A. Busch, S. Michel, C. Hoppe, D. Driesch, U. Claussen, and F. von Eggeling
Proteome Analysis of Maternal Serum Samples for Trisomy 21 Pregnancies Using ProteinChip Arrays and Bioinformatics
J. Histochem. Cytochem., March 1, 2005; 53(3): 341 - 343.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Melle, G. Ernst, B. Schimmel, A. Bleul, S. Koscielny, A. Wiesner, R. Bogumil, U. Moller, D. Osterloh, K.-J. Halbhuber, et al.
A Technical Triade for Proteomic Identification and Characterization of Cancer Biomarkers
Cancer Res., June 15, 2004; 64(12): 4099 - 4104.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement